Table 6.

MBL2 polymorphism associations with bacterial infections

MBL variantSample group, total no. in groupTotal no. with variantBacterial infection when variant is present, no. (%)Bacterial infection when variant is absent, no. (%)POR (95% CI)
Coding mutation Donor, n = 90 38 29  (76) 23  (44) .002 4.1  (1.6-10.3)  
 Recipient, n = 93 38 27  (71) 27  (49) .04 2.4  (1.1-6.3)  
HYA haplotype Donor, n = 90 54 25  (46) 30  (81) .0008 0.2  (0.08-0.54)  
 Recipient, n = 93 56 26  (46) 30  (79) .001 0.23  (0.09-0.59) 
MBL variantSample group, total no. in groupTotal no. with variantBacterial infection when variant is present, no. (%)Bacterial infection when variant is absent, no. (%)POR (95% CI)
Coding mutation Donor, n = 90 38 29  (76) 23  (44) .002 4.1  (1.6-10.3)  
 Recipient, n = 93 38 27  (71) 27  (49) .04 2.4  (1.1-6.3)  
HYA haplotype Donor, n = 90 54 25  (46) 30  (81) .0008 0.2  (0.08-0.54)  
 Recipient, n = 93 56 26  (46) 30  (79) .001 0.23  (0.09-0.59) 

MBL2 coding mutations and the HYA haplotype, when present in either donor or recipient, are associated with the occurrence of bacterial infection after SCT.

Close Modal

or Create an Account

Close Modal
Close Modal